Sana Biotechnology, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Sana Biotechnology, Inc. | SANA - NASDAQ |
$23.00-$24.00 | $25.00 | $35.00 | 23.5 million | 2/4/2021 |
| Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-13 Terms Added 2021-01-28 Amended Terms 2021-02-03 | ||||||
Sana Biotechnology, Inc. Quote & Chart - Click for current quote - SANA
IPO Boutique aggregates information on public companies and private companies, such as "SANA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Sana Biotechnology, Inc. (adapted from Sana Biotechnology, Inc. prospectus):
They have long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They have long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "SANA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.